Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01459666 · ClinicalTrials.gov registry record · Phase 4
Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
A Phase 4 study, sponsored by University Hospitals Cleveland Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT01459666: Clinical Trial Phase 4 study, sponsored by University Hospitals Cleveland Medical Center.
NCT01459666 is a Phase 4 study that was terminated before completion, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 9 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01459666, a Phase 4 study, was terminated before completion, sponsored by University Hospitals Cleveland Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study will test if the use of DysportTM (abobotulinumtoxinA) improves wound healing and scarring after Mohs surgery. Research in the laboratory as well as previous studies in humans have shown improved wound healing and scarring with the use of a similar medication called Botox. Dysport may improve wound healing and scarring by relaxing facial muscles and therefore minimizes the muscle tension and possibly the inflammation around the wound.
Primary Outcome
It consists of a 10 point scale to assess global scar assessment. Scar photographic images are assessed by independent physicians, and previous studies have shown very high intrarater consistency.
Interventions
- DRUG Dysport (abobotulinumtoxinA)
- DRUG Bacteriostatic 0.9% Sodium Chloride (vehicle)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-09 |
| Est. Completion | 2019-08 |
| Phase | Phase 4 |
Why NCT01459666 stopped before completion
NCT01459666 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Dysport (abobotulinumtoxinA) is the first listed.
NCT01459666 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01459666 about?
NCT01459666 is a clinical study titled "Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer". This study will test if the use of DysportTM (abobotulinumtoxinA) improves wound healing and scarring after Mohs surgery. Research in the laboratory as well as previous studies in humans have shown improved wound healing and scarring with the use of a similar medication called Botox. Dysport may im...
What is the current status of trial NCT01459666?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2011-09. Estimated completion is 2019-08.
What interventions are being tested in trial NCT01459666?
The interventions under investigation include: Dysport (abobotulinumtoxinA) (DRUG), Bacteriostatic 0.9% Sodium Chloride (vehicle) (DRUG).
Who is sponsoring clinical trial NCT01459666?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01459666's enrollment target sits among peer trials
9 1968th of 2000 higher than 29 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia